Psychiatry and Neurology, Neurology · Rhinelander, WI
NPI
1912060971
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2251 N Shore Dr
Rhinelander, WI, 54501
Phone (715) 361-2000
Groups this clinician bills Medicare through
Medicare paid, 2022
$34K
502 services
Medicare patients, 2022
315
Average age 69
Drug cost, 2024
$2.4M
7,239 prescriptions
Company payments, 2024
$21.62
From 1 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Mark T Szmanda was code 99214 (office e&m - established), 355 times for 216 patients. In total Mark T Szmanda billed 502 services in 8 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 355 | 216 | $61.37 | $22K |
| 99204 Office E&M - New | Facility | 114 | 114 | $93.25 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Mark T Szmanda prescribed most often to Medicare patients was Gabapentin, with 479 prescriptions and refills. In total Mark T Szmanda wrote 7,239 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 479 | 666 | 87 | $9,299 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 473 | 867 | 119 | $16K |
| Levetiracetam Generic | 417 | 730 | 80 | $10K |
| Memantine Hcl Generic | 319 | 442 | 59 | $6,901 |
| Lamotrigine Generic | 306 | 455 | 44 | $4,008 |
| Donepezil Hcl Generic | 248 | 426 | 51 | $2,680 |
| Topiramate Generic | 245 | 378 | 39 | $3,963 |
| Aimovig Autoinjector Erenumab-Aooe | 240 | 285 | 37 | $218K |
| Emgality Pen Galcanezumab-Gnlm | 194 | 206 | 31 | $157K |
| Duloxetine Hcl Generic | 183 | 266 | 30 | $3,529 |
| Primidone Generic | 167 | 259 | 33 | $3,291 |
| Pregabalin Generic | 148 | 180 | 18 | $2,472 |
| Lacosamide Generic | 141 | 168 | 16 | $36K |
| Sumatriptan Succinate Generic | 135 | 137 | 24 | $1,907 |
| Nurtec Odt Rimegepant Sulfate | 135 | 136 | 29 | $210K |
Brand drugs: 1,037 claims; generic drugs: 6,147 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark T Szmanda $21.62 ($21.62 in general payments such as food, travel and fees) from 1 company. The largest payer was Biogen, Inc. with $21.62.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 1 | $21.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.